ReviewClinical journal of the American Society of Nephrology : CJASN2026
Cardiovascular Disease in CKD: Ethnic and Regional Differences in Risk and Phenotype.
Review in Clinical journal of the American Society of Nephrology : CJASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in patients with CKD. Although the association between CKD and CVD is well established, the overall CVD burden, dominant cardiovascular phenotypes, and clinical outcomes vary substantially across populations. These differences are often described using racial or ethnic categories, yet emerging evidence suggests that they more closely reflect variation in cardiometabolic risk, inflammatory burden, environmental exposures, and health care access than race itself. This review synthesizes evidence from major CKD cohorts, including Chronic Renal Insufficiency Cohort (United States), German CKD, Chronic Renal Insufficiency Standards Implementation Study, and European Quality Study (Europe) and CKD Japan Cohort (Japan), Chinese Cohort Study of CKD (China), and KoreaN Cohort Study for Outcomes in Patients With CKD (Korea), to examine global patterns of cardiovascular burden and outcomes in CKD. North American and European CKD cohorts are characterized by greater inflammatory burden, more severe coronary artery calcification, and more pronounced left ventricular hypertrophy, corresponding to a clinical trajectory more heavily dominated by cardiovascular events and mortality. By contrast, East Asian cohorts show fewer overt atherosclerotic and cardiac structural abnormalities and a more kidney-dominant trajectory, in which kidney outcomes are more prominent relative to cardiovascular events. Genetic, environmental, and lifestyle-related modifiers likely contribute to these divergent cardiorenal phenotypes. Collectively, current evidence supports moving beyond race-based descriptions toward phenotype-informed and exposure-informed approaches to cardiovascular risk assessment in CKD, in which integration of imaging markers, inflammatory biomarkers, and cardiometabolic profiles may improve the precision and equity of cardiovascular prevention strategies across diverse CKD populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.